People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FlightPath Biosciences, Inc. | — | Biotechnology | Series A | $9.6M | $82.4M | 2023 |
Matthew Tindall at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Tindall on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark De Souza | 1 | 10 |
| Mark P. De Souza | 1 | 7 |
| Curtis Scribner | 1 | 1 |
| Cristina Larkin | 1 | 1 |
| Curtis L. Scribner | 1 | 1 |
| Matthew Charles Tindall | 1 | 1 |
| Jayakumar Charles Rajadas | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.